Atrial Fibrillation Clinical Trials in Shantou, Guangdong
2 recruitingShantou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Not Applicable
Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion
Cardiovascular DiseasesAtrial FibrillationArrhythmias, Cardiac+1 more
First Affiliated Hospital of Shantou University Medical College238 enrolled5 locationsNCT06455644